- Aboriginal Affairs
- Economic Development
- Intellectual Property
- Internal Trade
- International Trade
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Policies or Program
- Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim.
- Participation in discussions with respect to free trade discussions with the USA and Mexico.
- Pharmaceutical pricing policy arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB)
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Agriculture and Agri-Food Canada (AAFC)
Canada Foundation for Innovation
Finance Canada (FIN)
Health Canada (HC)
House of Commons
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
No government funding was received during the last completed financial year.
Client Contact Information
5180 South Service Road
Burlington, ON L7L 5H4
Mehmood Alibhai, Director, National Policy & Market Access
Parent Company Information
- Boehringer Ingelheim International GmbH
Binger Str 173
Ingelheim am Rhein 55216
Coalition Members Information
Boehringer Ingelheim is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Boehringer Ingelheim are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Boehringer Ingelheim does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
No public offices held
1 Rideau St Suite 700, Ottawa, ON K1N 8S7
Ottawa, ON K2B 7Y7
Consultant Firm and Address
Wellington-Dupont Public Affairs
2100 Thurston Drive
Ottawa, ON K1G 4K8